日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A genetically encoded biosensor for point-of-care and live-cell detection of D-2-hydroxyglutarate.

一种用于即时检测和活细胞检测 D-2-羟基戊二酸的基因编码生物传感器

Liu Yidong, Kang Zhaoqi, Xu Rong, Hou Shuang, Gong Lingru, Guo Leilei, Gao Kaiyu, Xu Xianzhi, Tan Xiaoxu, Xiao Dan, Zhang Wen, Wang Gang, Ou Shaowu, Hu Jinqu, Liu Jiyuan, Lü Chuanjuan, Ma Cuiqing, Xu Ping, Gao Chao

Nanoparticles for efficient drug delivery and drug resistance in glioma: New perspectives

纳米颗粒在胶质瘤高效药物递送和耐药性方面的应用:新的视角

Liu, Jiyuan; Yang, Fan; Hu, Jinqu; Zhang, Xiuchun

Establishment and validation of a novel integrin-based prognostic gene signature that sub-classifies gliomas and effectively predicts immunosuppressive microenvironment

建立并验证一种新型的基于整合素的预后基因特征,该特征可对胶质瘤进行亚分类并有效预测免疫抑制微环境

Qi, Chunxiao; Lei, Lei; Hu, Jinqu; Ou, Shaowu

Identification of a five-gene signature deriving from the vacuolar ATPase (V-ATPase) sub-classifies gliomas and decides prognoses and immune microenvironment alterations

鉴定出源自液泡ATPase(V-ATPase)的五基因特征,可对胶质瘤进行亚分类,并决定预后和免疫微环境的改变。

Qi, Chunxiao; Lei, Lei; Hu, Jinqu; Wang, Gang; Liu, Jiyuan; Ou, Shaowu

Thrombospondin-1 is a prognostic biomarker and is correlated with tumor immune microenvironment in glioblastoma

血小板反应蛋白-1是一种预后生物标志物,与胶质母细胞瘤的肿瘤免疫微环境相关。

Qi, Chunxiao; Lei, Lei; Hu, Jinqu; Wang, Gang; Liu, Jiyuan; Ou, Shaowu

Serine Incorporator 2 (SERINC2) Expression Predicts an Unfavorable Prognosis of Low-Grade Glioma (LGG): Evidence from Bioinformatics Analysis

丝氨酸掺入蛋白2 (SERINC2) 表达预示低级别胶质瘤 (LGG) 预后不良:生物信息学分析证据

Qi, Chunxiao; Lei, Lei; Hu, Jinqu; Wang, Gang; Liu, Jiyuan; Ou, Shaowu